Retinoids are important signal molecules during vertebrate embryonic development and their synthesis as well as catabolism should therefore be strictly regulated. The retinoic acid (RA) 4-hydroxylase, belonging to the cytochrome P450 family CYP26, is an enzyme catalyzing the 4-hydroxylation of RA, thereby regulating RA homeostasis. Here we describe the temporal and spatial expression patterns of mouse (mCYP26) and Xenopus laevis (xCYP26) homologues. In mouse, expression is detected in uterine crypt, around differentiating cartilage, several regions of the head, regions of the pharynx, the neural retina, and several regions of the trunk. In Xenopus, Northern blot analysis shows presence of xCYP26 transcripts before the MBT and an increased expression level during gastrulation. Whole-mount in situ hybridization shows a specific expression pattern arising at onset of gastrulation, with a ring around the blastopore. By mid gastrulation there is an anterior and a posterior expression domain, each of which gets more complex later in development. There are some important similarities and differences in expression pattern between Xenopus and mouse.
Vitamin A (retinol)-derived retinoids, including the biologically active molecule retinoic acid (RA), are believed to play an important role in regulating cellular growth, differentiation, and vertebrate embryonic development (Gudas et al., 1994) . Indeed, RA is a candidate molecule for the transformation signal described in the activation/transformation model for neural patterning in the early amphibian embryo (Nieuwkoop et al., 1952) . However, studies in Xenopus laevis gastrula embryos indicate that RA is not present at detectable levels (Blumberg et al., 1996) , while its 4-oxo counterpart 4-oxo-retinoic acid (4-oxo-RA) (Pijnappel et al., 1993) has been detected in Xenopus embryos and turned out to be both a strong teratogen and a ligand for the retinoic acid receptor (RAR; reviewed by Mangelsdorf et al., 1994) .
A RA-inducible RA 4-hydroxylase catalyzes the first step in the synthesis of 4-oxo-RA from RA (White et al., 1997; Sonneveld et al., 1998) and has recently been cloned from zebrafish (White et al., 1996) , mouse (Fujii et al., 1997; Ray et al., 1997) , and human (White et al., 1997) and was defined as a member of a novel cytochrome P450 subfamily CYP26. Here we describe the expression patterns of CYP26 during mouse and Xenopus laevis embryogenesis.
The major early embryonic expression domains of mouse CYP26 were described recently (Fujii et al., 1997) , and include the posterior neural plate and neural crest for cranial ganglia. At embryonic day (E) 7.5, mCYP26 is expressed in the anterior neural fold ectoderm and associated mesoderm (Fig. 1A) (Fujii et al., 1997) , while at E 8.5, this anterior expression is lost and expression appears in the caudal midline ectoderm including primitive streak and newly formed mesoderm (not shown) (Fujii et al., 1997) .
In E 7.5 extra-embryonic tissue, mCYP26 expression is detected in parietal and visceral endoderm (Fig. 1A) (Fujii et al., 1997) , in the posterior half of the amnion, in the allantois (Fig. 1A) , and in the uterine crypt of the deciduum (Fig. 1B) . Expression in this last domain can be strongly increased by RA treatment (Fig. 1C ).
In the head region, mCYP26 transcripts are detected in the hindbrain at E 9.5 (Fig. 1D) , and at E 9.5-11.5 in cephalic mesenchyme surrounding head veins, trigeminal and facioacoustic ganglions, ventral epithelium of the otic vesicle, the lateral part of the mandibular arch (Fig. 1E) (Fujii et al., 1997) , epithelium covering the nasal processes and maxillary arch (Fig. 1F) , and epithelium of the first three branchial pouches ( Fig. 1E and not shown). At E 12.5, the periotic mesenchyme expression becomes restricted to the periphery of the condensing mesenchyme of the otic capsule ( Fig. 1K ) and is lost by E 13.5. At E 12.5 and E 13.5, mCYP26 is expressed in the epithelium of the ventral side of the lateral and posterior semi-circular ducts, and ventrally in the cochlea ( Fig. 1K and not shown). At E 11.5-12.5, expression is broad in oral epithelium of both maxilla and mandible ( Fig. 1L ), which becomes restricted to the tooth buds at E 13.5 (not shown). Other areas of expression in the oral region include the tongue epithelium and an extensive domain running medially alongside Meckel's cartilage at E 12.5-13.5 (Fig. 1L) , and in the olfactory epithelium at E 11.5-12.5 (Fig. 1J ). The periocular mesenchyme shows low levels of expression from E 9.5 onwards, which appear to be restricted to the ocular muscles at E 12.5 (Fig. 1M) . From E 10.5-13.5, mCYP26 expression is found in a horizontal stripe in the dorsal half of the neural retina ( Fig. 1M ) (Fujii et al., 1997) . Weak expression is visible in the lens vesicle at E 10.5 only (not shown). In the trunk, mCYP26 is expressed at a low level in the nephrogenic cords at E 9.5, and in the mesonephric ducts at E 10.5 (Fig. 1G ). Higher expression is found in the ventral body wall (E 9.5-12.5; Fig. 1I ), amnion (E 9.5-12.5; Fig.  1I ), outer mesenchyme of oesophagus and stomach ( Fig.  1N-P) , anterior dorsal mesentery (E 10.5-11.5; Fig. 1O ), septum transversum and diaphragm (E 11.5-13.5; Fig. 1N ), presumptive muscle precursors (Fig. 1R) , walls of the dorsal aorta, the vitelline arteries and veins (not shown), dorsal side of the cloaca (Fig. 1H) and hindgut (not shown), sclerotome of the somites, and rib cartilage condensations (Fig.  1P,R) . As soon as limb buds appear, mCYP26 is expressed in the epithelium of both fore-and hind limb up to E 11.5 (Fig. 1I) . From E 12.5 onwards, expression can be detected around the cartilage condensations of the digits (Fig. 1Q ) (Fujii et al., 1997 ). An overview of the mouse expression data is given in Table 1 .
In Xenopus laevis, Northern blot analysis reveals expression of xCYP26 from before the MBT until the tailbud stage with a peak during gastrulation (Fig. 2 ). Treating embryos with RA for 1 h at different developmental stages leads to an increase of xCYP26 mRNA levels, most obvious at gastrula and neurula stages (Fig. 2) . Enhanced expression of xCYP26 following RA treatment can also be detected by in situ hybridization, all over the embryo at all stages tested (stage 10, 11, 16, 20 and 25; only shown for stage 16 in Fig. 3H ). Whole-mount in situ hybridization on untreated embryos shows xCYP26 transcripts in the mesoderm around the future blastopore at the onset of gastrulation (stage 10; Fig. 3 ). In early gastrula (stage 10.5; Fig.  3B ), this expression ring intensifies and staining is now also observed in the dorsoanterior region. The intense staining of the mesoderm ring parallels the expression observed in the mesoderm of the early-primitive streak E 7 mouse embryo (Fujii et al., 1997) . By the late gastrula (stage 12.5; Fig. 3C ), a posterior-expression domain, as a broad ring around the yolk plug, and a dorsoanteriorexpression domain become well defined, but there is no expression within these domains in the dorsal midline (floorplate). This co-expression in the anterior and posterior regions was also shown in the early mouse embryo (E 7 and E 7.25) (Fujii et al., 1997) . By neurula stage 17 (Fig.  3D) , there is still strong expression around the blastopore. More anteriorly, expression is now observed in the cement gland, at the lateral border of the anterior neural plate, and at the edge of the neural fold at the level of the future hindbrain. Based on timing and localization we suggest that the latter expression is in neural crest cells, as has been reported for mouse embryos (E 8.5) (Fujii et al., 1997) . Neurula stage-21 embryos (Fig. 3E) still express xCYP26 posteriorly, but transcripts are also present in the somitic mesoderm. Anteriorly, xCYP26 is expressed in the branchial arches and in the central nervous system at the level of the anterior rhombencephalon. This latter expression parallels the expression reported in the rhombencephalon of the mouse (Fujii et al., 1997) (Fig. 1D) . The expression pattern seen in stage-21 neurula embryos is still maintained in tailbud embryos (stage 26; Fig. 3F ). By later tailbud stages (stage 32; Fig. 3D ), xCYP26 is still expressed in the tip of the tail, in the branchial arches, and the somitic mesoderm, but also in the eye cup, the lens anlage and the olfactory placode. It is noteworthy that no expression was observed in the primary eye vesicle or in the early olfactory placode of stage-26 tailbud embryos. Most of the expression regions described for stage-32 tailbud embryos correlate with expression domains in the mouse: i.e. in the eye (Fig. 3M) , the olfactory placode (Fig. 3F,J) , the tip of the tail (Fig. 3J) (Fujii et al., 1997) and the somitic mesoderm (Fig. 3R) . However, no xCYP26 expression is detected in the otic vesicle.
These studies indicate that most CYP26 expression domains are conserved between mouse and Xenopus, although there are also some clear differences.
Materials and methods

Cloning of Xenopus and mouse CYP26 fragments
Xenopus and mouse CYP26 fragments were cloned by PCR from reverse transcribed cDNA from RA-treated stage-12 Xenopus embryos, and RA-treated P19-EC cells (16 h 1 mM RA), respectively. Based on amino acid homology between zebrafish CYP26 (zCYP26) and mCYP26, the following primer sets were used for Xenopus: 5′-ggaattcga(a/g)gc(a/t/g/c)tt(t/c)ga(a/g)ga(a/g)atg-3′ (forward) and 5′-gggatcc(a/t/g/c)ac(a/g)ttcca(a/t/g/c)cc(t/c)tt-3′ (reverse). While these studies were in progress, a Xenopus laevis retinoic acid converting enzyme (RACE) was submitted to the GenBank (accession AF057566). This RACE showed 68% amino acid homology to mCYP26, which matches the homology between zCYP26 and mCYP26. Based on alignment results (not shown) we conclude that the RACE is the Xenopus homologue of CYP26. The obtained Xenopus gene fragment (nt.624-nt.1170) showed 100% amino acid homology to this RACE and was used in the expression studies described here. For mouse, the following primers were used: 5′-cgagaagagataaagagcaagggc-3′ (forward) and 5′-ggaggtccatttagaagctgcc-3′ (reverse). The mouse cDNA fragment corresponds to nt.1019-nt.1336 of the recently cloned mouse CYP26 (Ray et al., 1997) .
Embryos and retinoic acid treatment
Xenopus embryos were obtained by in vitro fertilization, cultured in tap water containing gentamycin (50 g/l) and staged according to Nieuwkoop and Faber (1967) . RA treatment was performed in tap water containing 10 − 6 M RA (10 embryos/5 ml). Pregnant mice (6.5 days post coitum) were injected i.p. with 0.3 mg RA dissolved in arachis oil. Decidua were isolated at E 7.5. Xenopus embryos used for whole-mount in situ hybridization were fixed in MEMFA (Harland, 1991) for 2 h at room temperature, washed once in methanol and stored at −20°C in fresh methanol.
In situ hybridization
Digoxigenin (DIG)-labelled xCYP26 and 35 S-labelled mCYP26 antisense riboprobes were generated by in vitro transcription. The whole-mount in situ hybridization procedure for Xenopus embryos was as described by Harland (1991) , with modifications as described by Van der Wees et al. (1996) and BM purple AP substrate (Boehringer-Mannheim) as staining reagent. Analysis of the staining pattern was performed in Murrays (1:2 benzyl alcohol: benzyl benzoate). In situ hybridization on mouse sections with 35 S-labelled transcripts was performed according to Wilkinson (1993) . To obtain bright and dark field images superimposed in the same picture, slides were exposed twice; with a blue filter over the bright field image and a red filter over the dark field image. mCYP26 sense probe gave no signal (not shown).
Northern blot
RNA was isolated using TriPure isolation reagent (Boehringer-Mannheim), separated on an agarose gel and electroblotted on positively charged nylon membrane (Boehringer-Mannheim). The blot was hybridized at 68°C to the DIG-labelled RNA probe described for whole-mount in situ hybridization. Washes were with 0.1 × SSC at 68°C. Detection was with anti-DIG-AP Fab fragment and CDP-star (Boehringer-Mannheim).
Note added in proof
While in press, another report describing the cloning and expression of Xenopus CYP26 was published [Embo. J. 17, [7361] [7362] [7363] [7364] [7365] [7366] [7367] [7368] [7369] [7370] [7371] [7372] . The results presented in this article are consistent with our data.
